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Copyright © 2008 JCBN Summary During the lipid peroxidation reaction, lipid hydroperoxides are formed as primary
products. Several lines of evidence suggest that lipid hydroperoxides can trigger cell death in
many cell types, including neurons. In a screening of lipid hydroperoxides which can induce
toxicity in neuronal cells, we found docosahexaenoic acid hydroperoxides (DHA-OOH)
induced much severe levels of reactive oxygen species generation and cell death in
human neuroblastoma SH-SY5Y cells compared to the hydroperoxides of linoleic acid and
arachidonic acid. Therefore, we focused on DHA-OOH, and demonstrated that DHA-OOH
apparently induced an apoptosis in the neuronal cells through several apoptotic hallmarks
including nuclei condensation, DNA fragmentation, poly (ADP-ribose) polymerase cleavage
and increased activity of caspase-3. We also found the signaling changes in mitochondria-
mediated apoptosis, such as cytochrome c release and increased expression of Bcl-2, as well as
a dose-dependent attenuation of mitochondrial membrane potential in the DHA-OOH treated
cells. These data indicated DHA hydroperoxide as a potential inducer of apoptosis in human
neuroblastoma SH-SY5Y cells, which may be mediated by mitochondria dysfunction pathway.
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Introduction
Polyunsaturated fatty acids (PUFA), such as linoleic acid
(C18:2, ω6) (LA), arachidonic acid (C20:4, ω6) (AA) and
docosahexaenoic acid (C22:6, ω3) (DHA), are essential for
the maintenance of the normal biological functions; however,
they are highly unsaturated and, therefore, are the most
vulnerable for free radical damage termed lipid peroxidation
[1]. Lipid peroxidation in tissue and in tissue fractions
represents a degradative process, has been implicated in the
pathogenesis of numerous diseases, such as atherosclerosis,
diabetes, cancer, as well as several neurodegenerative
diseases [2]. During the lipid peroxidation, lipid hydro-
peroxides are formed as primary products. It has been
reported that lipid hydroperoxides also possess highly
reactive biological properties like as subsequent secondary
product aldehydes, both of which can react on proteins to
form adducts, alter cellular responses, and induce apoptosis
in many cell lines [3–6].
In the brain, a high concentration of polyunsaturated fatty
acids, especially DHA and AA, are implicated relative to
other organs, therefore, lipid peroxidation is one of the major
outcomes of free radical-mediated injury to brain, where it
directly damages membranes and generates a number of
oxidized products. In our previous report, we have in vivo
described the formation of a DHA hydroperoxides-derived
protein modified adduct Nε-(succinyl) lysine (SUL); more-DHA-OOH-induced Neuronal Apoptosis
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over, the formation of SUL was then immunochemically
demonstrated in the liver of mice fed with DHA followed by
intraperitoneal injection of carbon tetrachloride (CCl4), a
hepatic lipid peroxidation model [4]. In addition, Nathalie
Bernoud-Hubac  et al. have identified. γ-ketoaldehyde
isoketals (Isoks) derived from AA and neuroketals
(NeuroKs) derived from DHA [7]. Although the patho-
physiological consequence of the overproduction of the lipid
peroxidative products have been highlighted in brain tissue,
it is noteworthy that these reactive products are also gener-
ated at low levels in neuronal membrane and appear to play
a role in physiological signaling of neuron, such as apoptosis
[8].
Apoptosis has been considered the main cause of neuronal
death in some human neurodegenerative disorders, such as
Alzheimer disease (AD) [9]. In recent years, many reports
have focused on aldehydes to investigate the effect of lipid
peroxidation on apoptosis in neuronal cells, whereas
although little was known, the primary products of lipid
peroxidation, hydroperoxides, may also be greatly account
for the disorders of neuronal cells. In the present study,
through a screening we found that DHA hydroperoxides
(DHA-OOH) showed a much severe toxic effect to neuronal
cells, thus, we focused on DHA-OOH to investigate whether
and how it induced an apoptotic cell death in human
neuroblstoma SH-SY5Y cells. The exploration may provide
new clues to the pathogenic mechanism in neurodegenera-
tive diseases.
Materials and Methods
Materials
DHA (purity≥98%) was purchased from the Cayman
Chemical Co. (Ann Arbor, MI). Arachidonic acid and α-
linolenic acid were obtained from the Sigma-Aldrich Co.
(St. Louis, MO). The antibodies against poly (ADP-ribose)
polymerase (PARP) were purchased from the Cell Signaling
Technology, Inc. (Beverly, MA). The antibodies against
Bcl-2 (100) and Bax were obtained from the Santa Cruz
Biotechnology (Santa Cruz, CA). Purified Mouse Anti-
Caspase-3 (CPP32, not recognizing cleaved form of
caspase-3 in the western blot) and purified Mouse Anti-
cytochrome c were obtained from BD Pharmingen (Franklin
Lakes, NJ). 13-Hydroperoxy-octadecadienoic acid (13-
HPODE) and 15-hydroxyeicosatetraenoic acid (15-HPETE)
were enzymatically synthesized from linoleate and arachi-
donic acid, respectively, by soybean lipoxygenase as previ-
ously described [10, 11].
DHA hydroperoxides preparation
The DHA-OOH was prepared by the reaction of lipoxi-
dase (from soybean, Wako Pure Chemical Industries, Ltd.,
City, Japan) with docosahexaenioc acid as previously de-
scribed [12]. The reaction mixture containing 83.6 mg
docosahexaenoic acid, 16 mg lipoxidase and 220 ml of
borate buffer (200 mM, pH 9.0) were used, and the reaction
was carried out in a flask filled with oxygen at room
temperature. After incubation for 10 min, to terminate the
reaction, HCL was added to the mixture till the solution pH
was below 4.0. The formed hydroperoides were extracted
twice with an equal amount of chloroform/methanol (1:1),
and the collected chloroform layer was then evaporated. The
obtained DHA-OOH was dissolved in ethanol. The identifi-
cation was performed by HPLC analysis monitored at A234
and the concentration was quantified using a lipid hydro-
peroxide kit (Cayman, Ann Arbor, Michigan) compared to a
standard curve prepared by authentic 13-HPODE.
13-HPODE preparation
The hydroperoxide of linoleic acid, 13-HPOD, was made
from linoleic acid by soybean lipoxygenase (SLO) as pre-
viously described [10]. The linoleic acid (0.7 mg/ml) was
dissolved in 0.1 M borate buffer (pH 9.0). SLO (7600 unit/
ml) was added to the solution and reacted under O2 with
stirring at room temperature. After 90 min, the pH was
adjusted to 4.0 with 0.1 M HCl for the termination of the
oxidation. The peroxide formed was extracted with a 2-fold
volume of chloroform-methanol 1:1. The extract was evapo-
rated, dissolved in chloroform, and then applied to a thin-
layer chromatography (TLC) plate. The chromatography
was performed using a development with n-hexane-diethyl
ether 4:6. The band of 13-HPODE was visualized by a W
lamp and scraped off. The 13-HPODE was extracted with
chloroform andethanol and stored under argon at −70°C or
−20°C before use. The identification was performed on the
basis of 'H-nuclear magnetic resonance spectrometry and
coelution of HPLC with authentic 13-HPODE commercially
obtained. The concentration of 13-HPODE was determined
by absorbance at 234 nm using E = 25000 M-' cm-'.
15-HPETE preparation
15-HPETE was synthesized from 25 μM of arachidonic
acid in 30 ml of 0.1 M Tris, pH 9.0 that had been saturated
with oxygen as described in reference 11. The reaction was
initiated by adding 0.25 × 106 U of 15-lipoxygenase and
proceeded for 2 min at room temperature. Subsequently, a
second aliquot of 15-lipoxygenase (0.25 × 106 U) was
added, and the reaction continued for an additional 8 min.
Oxygen was gently bubbled into the buffer throughout the
reaction. Formation of 15-HPETE was monitored by an
increase in A235. The reaction was stopped by adding 7.5 ml
of ethanol and chilling on ice. After acidification to pH 3
with 12 N HCl, lipids were extracted three times with 4
volumes of ethyl acetate/hexane (1:1). The combined
organic layers were dried over anhydrous sodium sulfate
and concentrated by a stream of nitrogen gas. The extractsX. Liu et al.
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were applied to a silica HPLC semi-preparative column
(Waters Spherisorb S10 W, 5 μm, 10 × 250 mm) and eluted
isocratically with hexane/isopropanol/acetic acid (985:15:1,
v/v/v) at a flow rate of 2.0 ml/min; the eluate was monitored
by  A234. Fractions containing 15-HPETE were combined,
concentrated by evaporation with a stream of nitrogen gas
and stored at −20°C. The concentration of 15-HPETE was
determined using ε234 =2 3m M −1cm−1.
Cell culture and cell viability
Human neuroblastoma SH-SY5Y cells were grown in
Cosmedium-001 (Cosmo-Bio, Tokyo, Japan) containing 5%
fetal bovine serum. The cells were seeded in plates coated
with polylysine and cultured at 37°C. The cell viability was
quantified by MTT assay.
Analysis of reactive oxygen species (ROS) production
The endogenous ROS level was detected by flow cyto-
metry using H2DCF-DA as previously described [12]. In
the present study, the SH-SY5Y cells were treated with
DHA-OOH (10 μM) for 30 min, followed by staining with
DCHF-DA (100 uM) for an additional 30 min. The fluore-
scence of dichlorofluorescein (DCF) in the supernatant was
measured by an EPICS Elite Flow Cytometer.
Nuclear staining assay
To determine the apoptotic nuclei, cells treated with
10 μM DHA-OOH for 4 h were stained with a fluorescent
DNA-binding dye, Hoechst 33258, and observed using a
fluorescence microscope (Olympus Optical Co., Ltd., Tokyo,
Japan).
Analysis of DNA fragmentation
For analysis of the DNA fragmentation by agarose gel
electrophoresis, the cellular DNA was extracted from whole
cells treated with 10 μM DHA-OOH. Analysis of DNA
fragmentation was performed as described previously [3].
Subcellular fraction of SH-SY5Y cells
Subcellular isolation from the cells was carried out as
described by Pallotti et al. [13]. Briefly, cells are harvested
by centrifugation at 600 × g for 10 min, washed with PBS,
and resuspended with 5 volumes of Solution A (0.25 M
sucrose, 20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM
MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol,
0.1 mM PMSF). The cellular suspension was homogenized
with a glass-glass homogenizer with 20 up and down passes
of the pestle. The homogenate was then centrifuged at
750 × g for 10 min. The resulting supernatant was collected,
and then centrifuged at 10,000 × g for 15 min. The superna-
tant was used as the cytosol fraction.
Fig. 1. ROS generation and cell viability. A, Scheme for the formation of lipid hydroperoxides. B, ROS generation. The cells were
loaded with carboxy-H2DCFDA for 30 min, followed by exposure to 10 µM PUFA or lipid hydroperoxides for 45 min. The
carboxy-H2DCFDA-loaded cells without any treatment were used as the control. C, Cytotoxicity. The cells were exposed to
10 µM of different agents for 0–24 h. Cell viability was measured by the MTT assay. In the MTT assay, data are expressed as %
of control culture conditions. Open square, DHA; closed square, DHA-OOH; open triangle, linoleic acid (LA); closed triangle,
13-HPODE; open circle, Arachidonic acid (AA); closed circle, 15-HPETE.DHA-OOH-induced Neuronal Apoptosis
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Western blot analysis
The homogenates prepared from the cells were treated
with the SDS sample buffer and then immediately boiled for
5 min. The protein concentrations were determined using
the BCA protein assay kit (Pierce, Rockford, USA). The
proteins were separated by SDS-PAGE in the presence of
2-mercaptoethanol and electrotransferred onto a nitro-
cellulose membrane (Hybond ECL) (Amersham Biosciences,
Tokyo, Japan). To detect the immunoreactive proteins, we
used horseradish peroxidase-conjugated anti-rabbit or
mouse or goat IgG and ECL blotting reagents (Amersham
Biosciences, Tokyo, Japan).
Measurement of the mitochondrial membrane potential
The mitochondrial membrane potential was measured as
described by Ko et al. [14]. Briefly, SH-SY5Y cells after
different treatments were incubated with 50 nM DiOC6
for 30 min at 37°C, followed by washing with ice-cold PBS,
after which the cell pellets were collected. The pellets were
suspended in 600 μl of PBS, and the fluorescent intensities
of the cells were analyzed using an EPICS Elite Flow
Cytometer (Beckman Coulter, Inc., Fullerton, CA) at the
respective wavelengths for excitation and emission of 484
and 500 nm.
Results
ROS generation and cell viability
To identify what hydroperoxides can induce much severe
toxicity in neuronal cells, we conducted a screening of the
lipid hydroperoxides derived from DHA, AA and LA,
respectively, for ROS generation and cell viability in
neuroblastoma SH-SY5Y cells. As shown in Fig. 1, after
treatment with 10 μM of different agents for 30 min, signifi-
cant ROS generation induced by DHA-OOH was found
compared to that treated by 13-HPODE and 15-HPETE
which are major hydroperoxides derived from linoleic acid
and arachidonic acid, respectively (Fig. 1B). Moreover,
we measured the numbers of viable cells under exposure to
the hydroperoxides by MTT assay. Likewise, DHA-OOH
induced an apparent time-dependent decrease in the viable
cells at a concentration at 10 μM, whereas no significant cell
death was found up to 24 h when the cells were treated with
the same dose of 15-HPETE and 13-HPODE (Fig. 1C). In
addition, in both the ROS generation and cell death cases,
polyunsaturated fatty acids themselves almost exhibited no
effect on the neuronal cells.
Fig. 2. Induction of apoptotic cell death. A, Nuclei condensation in SH-SY5Y cells exposed to 10 µM DHA-OOH. SH-SY5Y cells were
stained with Hoechst 33258, and examined by fluorescence microscopy. Left panel, control. Right panel, DHA-OOH treatment.
B, DNA fragmentation in SH-SY5Y cells exposed to 10 µM DHA-OOH for 4 h. Nucleosomal DNA fragmentation was
visualized by agarose gel electrophoresis. C, PARP cleavage in SH-SY5Y cells exposed to DHA-OOH. The cleavage of PARP
was analyzed by Western blotting. Upper panel, time-dependent cleavage of PARP. Lower panel, dose-dependent cleavage.
D, Analysis of caspase-3 expression. The cells were treated with 10 µM DHA-OOH for 0–8 h. Expression of pro-caspase 3 was
detected by western blotting using caspase-3 antibody (not recognizing cleaved form of caspase-3 in the western blot).X. Liu et al.
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Induction of apoptotic cell death
Based on the identification that DHA-OOH significantly
led to a time-dependent decrease in the number of viable
cells (Fig. 1C), next we focused on DHA-OOH to
characterize whether DHA-OOH-induced cell death included
apoptosis in human neuroblastoma SH-SY5Y cells. When
human nueroblastoma SH-SY5Y cells were exposed to
10 μM DHA-OOH for 4 h, nuclei condensation was found
in cells implicating a typical morphological feature of
apoptosis (Fig. 2A). The gel electrophoresis of DNA from
SH-SY5Y cells treated with DHA-OOH also displayed
nucleosomal DNA fragmentation (Fig. 2B). Moreover, as
hallmarks of apoptosis, a dose and time- dependent
proteolytic cleavage of PARP resulting in the accumulation
of the 89-kDa (Fig. 2C), as well as a time-dependent
decrease in the pro-caspase 3 expression (Fig. 2D), was
seen in the cells after the treatment with DHA-OOH, thus
indicating that DHA-OOH induced an apoptosis in the
neuronal cells.
Cytochrome c release and Bax/Bcl-2 ratio increased in
response to DHA-OOH
The release of cytochrome c (Cyt c) from mitochondria
into the cytosol, followed by activity of caspase 3, has
been identified in the process of mitochondria-dependent
apoptosis. On the other hand, Bcl-2 family proteins have
been shown to be involved in Cyt c release through the
increasing translocation of the pro-apoptotic Bcl-2 family
proteins Bax to the mitochondria [15]. In this study, to
determine whether DHA-OOH-induced apoptosis is medi-
cated by a mitochondrial pathway, we examined the expres-
sion levels of Cyt c in the cytosol fraction, as well as Bcl-2
and Bax in the whole cell lysates. As shown in Fig. 3A,
treatment of the cells with 10 μM DHA-OOH cause a
significant increase in the Cyt c levels in the cytosol fraction
for 60 min. In addition, in this study, although significant
changes in the expression of Bax in the DHA-OOH-treated
cells were not observed, a time-dependent decrease in the
expression levels of Bcl-2 was found. Thus, an apparent
increase in the Bax/Bcl-2 ratio was determined by a densito-
metric analysis of the bands (Fig. 3B), which is thought to be
a key hallmark for the execution of apoptosis. These results
suggest that the apoptotic cell death induced by DHA-OOH
in SH-SY5Y cells may be mediated via the mitochondria
mediated pathway.
Loss of mitochondrial membrane potential
The involvement of mitochondria in the DHA-OOH
induced apoptosis process in SH-SY5Y cells focused our
attention on what has happened in the mitochondria in the
apoptotic cells, and thus we examined the function of mito-
chondria in the DHA-OOH-treated cells. The mitochondrial
membrane potential was measured by flow cytometry using
DiOC6 as a fluorescent dye. The data in Fig. 4A showed a
dose-dependent decrease in the mitochondrial membrane
potential in the DHA-OOH-treated SH-SY5Y cells, in
contrast, almost no attenuation of mitochondria membrane
potentials were detected in the 13-HPODE or 15-HPETE-
treated cells (Fig. 4B).
Discussion
It has long been thought that oxidative stress is involved
in the pathogenesis of neurodegenerative diseases including
AD and Parkinson diseases (PD) [16–19]. Recently, much
of the investigation has fueled interest in PUFA oxidation
in the molecular pathogenesis of the diseases, especially
AA (20:4, ω6) and DHA (22:6, ω3), which are evenly
Fig. 3. The increased cytochrome c release and Bax/Bcl-2
ratio in response to DHA-OOH. A, Cytochrome c
release. SH-SY5Y cells were treated with DHA-OOH
(10 uM) for different times (0, 15, 30 and 60 min), and
the cytosolic fraction were prepared. The expression of
cytochrome c in the fraction was detected by western
blotting. B, Expression of Bcl-2 family protein. The
whole lysates extracted from the DHA-OOH-treated
cells were used to analyze the expression of Bcl-2 family
protein by western blotting, and the ratio of Bax/Bcl-2
was analyzed. The results are the means of three
experiments.DHA-OOH-induced Neuronal Apoptosis
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distributed in the gray matter and white matter and enriched
in neuronal membranes, respectively [20, 21]. Regardless of
the oxidative damage of aldehydes to neuronal cells, the
primary product during PUFA oxidation, hydroperoxides,
have also been reported having a high biologic activity that
affects bodily functions [22]. For instance, AA-derived
hydroperoxide 15-HPETE induces apoptosis in human
neuroblastoma CHP 100 cells by increasing intracellular
calcium [23]. In this study, through a screening we found
that DHA-OOH showed a much severe neurotoxic effect,
including ROS generation and cell death induction,
compared to that of the hydroperoixdes derived from
arachidonic acid and linoleic acid. Additionally, it is
believed that the equal amounts of -OOH included in DHA-
OOH, 15-HPETE and 13-HPODE were added to the cells
because the concentration of the hydperoxides were
commuted prior to the administrations by lipid hydro-
peroxide kit (Cayman) compared to a standard curve pre-
pared by authentic 13-HPODE.
In the following investigation that focused on DHA-
OOH-induced neuronal cell death, we indicate that DHA-
OOH induced an apoptosis in SH-SY5Y cells, and suggest
the mechanism might be mediated by a mitochondria
dysfunction pathway. The results agree with Zhu et al. who
suggest that mitochondrial dysfunction may play very
important roles in neuronal apoptosis [24]. Moreover, it is
well known that mitochondria mediated neuronal apoptosis
is a common mechanism of cell loss in several neuro-
degenerative diseases, therefore, due to the high concentra-
tion of DHA in the brain and highly susceptible to oxidative
stress, DHA-OOH-induced apoptosis may be much involved
in the pathogenesis of neurodegenerative diseases.
DHA is well known as the main polyunsaturated fatty
acid enriched in the central system, especially, the brain. In
Fig. 4. Loss of mitochondrial membrane potential. A, SH-SY5Y cells were treated with different concentration of DHA-OOH (0, 2.5,
5, 10 μM). DiOC6 was added to the culture medium for a further 30 min. The fluorescence intensity of DiOC6 in cells was
analyzed by flow cytometry. B, As described in A, the effect of 13-HPODE and 15-HPETE to mitochondria membrane
potential were also measured compared to DHA-OOH.X. Liu et al.
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recent years, many papers have reported its beneficial
physiological effects, such as learning ability, and hypo-
lipidemic and neuroprotective effects [25–28]. However,
DHA is highly unsaturated and, therefore, is the most
vulnerable target for free radical damage termed lipid
peroxidation [1]. It has been implicated that DHA concentra-
tions decreased in the neurodegenerative brain [29],
although the precise mechanism for the decrease is not well
understood, it has been suggested that the lipid peroxidation
of DHA is associated with the loss due to the increased
detection of DHA peroxidative products in the patient’s
brain, such as 4-hydroxy-2-hexenal and NeuroKs [7, 30].
Despite the fact that DHA peroxidation is a significant
causal factor being responsible for the decrease in the DHA
concentration, on the other hand, it is possible that the
products of the DHA peroxidation may play some damaging
role in the neural systems, but as to this aspect little has
been investigated. In this study, the demonstration that
DHA-OOH can induce apoptosis in the neuronal cells, for
the first time, indicates DHA hydroperoxide as a potential
neurotoxic product.
Several lines of evidence suggest that lipid peroxidation
products represent potential intermediates for the oxidative
modification of proteins under oxidative stress [31–35]. In
our previous study [4], we characterized a specific mono-
clonal antibody 2B12 against SUL, which is an N-acyl-type
(amide-linkage) adduct generated from the reaction of
DHA-OOH with lysine residue, but not from the reaction of
aldehydes with the amino residues in vitro. Recently, by
using mAb 2B12, we have observed an intensive SUL
staining in the brain of Parkinson’s patients (Maruyama,
Osawa, unpublished data), as well as we found that SUL
significantly accumulated in the mitochondrial fraction
isolated from the DHA-OOH-treated cells (Data not shown).
Therefore, we suggest not only loss of mitochondria
membrane potential but also protein modification happened
in the mitochondria in the DHA-OOH-treated cells.
Pathologically, other than apoptosis as a common causal
or resulting feature, several disorders have been implicated
in neurodegenerative diseases, such as β-amyloid aggrega-
tion and a progressive loss of dopaminergic neurons which
are mostly characterized in AD and PD [36], respectively.
Our further challenge is to investigate the influence of a
DHA peroxidative product, namely DHA-OOH, on the other
neurodegenerative disorders.
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